Venomics AI raises $2.7M in pre-seed funding led by Speciale Invest and South Park Commons to advance venom-based drug discovery using AI and experimental screening.
Venomics AI, a biotechnology company spun out of the Indian Institute of Science, has raised $2.7 million in its first institutional funding round. The pre-seed round was co-led by Speciale Invest and South Park Commons, with participation from Operators Studio. The funding will support expansion of the Venom Atlas, a molecular dataset, and strengthen AI and laboratory screening capabilities. The company will also build its multidisciplinary team and validate promising venom-derived therapeutic molecules.
Who to call at Venomics AI, and when
A new round usually means Venomics AI is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Venomics AI raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Venomics AI, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Venomics AI. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Venomics AI
Location
Bengaluru, Karnataka, India
About
Venomics AI is a biotechnology company spun out of the Indian Institute of Science that combines venom biology, artificial intelligence, and experimental screening to discover venom-derived molecules for therapeutic development. The company has built the Venom Atlas, a molecular dataset, and uses AI to prioritize candidates while validating them through laboratory screening. By leveraging India's venom biodiversity and scientific expertise, Venomics AI aims to create a drug discovery platform for global therapeutic applications.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Venomics AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.